Dicot Pharma AB OMXSTO:DICOT:
SUBMITS PATENT APPLICATION FOR LIB-01
PATENT APPLICATION BASED ON LONG-TERM EFFECT FROM PHASE 2A STUDY
PATENT PROTECTION CURRENTLY LASTS UNTIL 2042
PHASE 2B STUDY PLANNED TO BEGIN IN 2026
Dicot Pharma AB OMXSTO:DICOT:
SUBMITS PATENT APPLICATION FOR LIB-01
PATENT APPLICATION BASED ON LONG-TERM EFFECT FROM PHASE 2A STUDY
PATENT PROTECTION CURRENTLY LASTS UNTIL 2042
PHASE 2B STUDY PLANNED TO BEGIN IN 2026